BridgeBio Oncology Therapeutics, Inc. (BBOT) › Capital ExpendituresBridgeBio Oncology Therapeutics, Inc. (BBOT) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2024: $49.0K2025: $606.0K$606.0K2024Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$606.0K+1136.7%2024$49.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share